Read the First Edition of The Lens, a new magazine by LSI
Published January 2021 | Forecasts through 2021
The COVID Impact on Global Medical Devices & Diagnostics Markets: 2020 Review & 2021 Forecast
image
Overview

The year 2020 has been both devastating and energizing for the global MD&D industry as a whole. The COVID-19 pandemic, whose impact first shut down and then curtailed routine medical, hospital and surgical care around the world, delayed normal market growth which, even now, is threatened by a possible second, mutation-induced pandemic. Hardest hit have been companies that serve surgical markets and those dominated by office- and clinic-based services, e.g., aesthetics, hearing, dental. On the other hand, developers of IVD tests that diagnose the SARS-CoV-2 virus and manufacturers of infection control disposables, critical care and respiratory products have seen their revenues skyrocket to the point that some have been unable to keep up with demand. The result has been a roller coaster but mostly disappointing year for the industry, although MD&D companies can take comfort in the knowledge that they have not faced these hardships by themselves and, as an industry, have actually responded to the pandemic with great competence, ingenuity and care for their employees, patients, clinicians and stockholders.

Earlier in the year, we published reports providing insights into: 1) the anticipated impact of the COVID-19 pandemic on the global MD&D market by major technology; and 2) MD&D companies’ apparent exposure to the pandemic based on the composition of their product portfolios. The current report provides a wrap up of the year’s positives and negatives. It forecasts 2020 revenues for 50 of the largest MD&D companies by franchise as well as forecasts for nearly 100 technologies grouped into 23 segments for 2020 and 2021. We did not venture beyond 2021 except to comment in the text on how far full recovery for a technology market might stretch into that year.

This new report quantifies the impact that COVID-19 has had on the global MD&D market and forecasts how we expect the market to rebound, by segment and by competitor.

Buy Neurovascular Devices for
Hemorrhagic Stroke Market Snapshot
Companies Covered

3M

Abbott Laboratories

AbbVie/Allergan plc

Alcon

Align Technology

Arthrex

Asahi Kasei

B. Braun Melsungen

Baxter International

Becton Dickinson

bioMerieux

Boston Scientific

Canon Medical Systems

Cardinal Health

Coloplast

ConvaTec

Cooper Companies

Danaher Corporation

Demant

Dentsply Sirona

Edwards Lifesciences

Elekta

Envista

Fresenius SE & Co. KGaA

FujiFilm

GE Healthcare

Getinge

Hillrom

Hologic

Intuitive Surgical

Johnson & Johnson

Medtronic

Mölnlycke

Nipro

Olympus Corporation

Philips Healthcare

ResMed

Roche Diagnostics

Siemens Healthineers

Smith & Nephew

Sonova

Steris

Straumann

Stryker

Sysmex

Teleflex

Terumo

Thermo Fisher Scientific

Varian Medical Systems

Zimmer-Biomet

Order individually or subscribe and
get a complete intel platform.

Trusted By The Companies Pioneering What’s Next